Table: begin end state 1 19 non-cytoplasmic 20 35 transmembrane 36 55 cytoplasmic 56 75 transmembrane 76 86 non-cytoplasmic 87 115 transmembrane 116 146 cytoplasmic 147 168 transmembrane 169 173 non-cytoplasmic 174 195 transmembrane 196 247 cytoplasmic 248 269 transmembrane 270 285 non-cytoplasmic 286 309 transmembrane 310 320 cytoplasmic 321 339 transmembrane 340 344 non-cytoplasmic 345 367 transmembrane 368 376 cytoplasmic 377 400 transmembrane 401 406 non-cytoplasmic 407 428 transmembrane 429 436 cytoplasmic
Input: >AO356_20295 FitnessBrowser__pseudo5_N2C3_1:AO356_20295 MQAHTLSAQASLVTPSRKRFFIMVLLFITVVINYLDRSNLSIAAPALTSDLGIDPIHVGL IFSAFGWTYAAMQIPGGWLVDRVPPRILYSVALLLWSVATVMLGFAASFIALFVLRMAVG ALEAPAYPINSRVVTTWFPERERATAIGFYTSGQFVGLAFLTPVLAWLQHAFGWHMVFVA TGAVGILWAVIWYAVYREPRDFKGANAAEIELIREGGGLVDIQADTAKVKAKFSWSDLGI VLTQRKLWGIYLGQFCLNSTLWFFLTWFPTYLVKYRGMDFIKSGLLASLPFLAAFVGVLC SGFFSDWLIRRGATVGFARKLPIIGGLLISTSIIGANFVESTPLVIAFLALAFFGNGLAS ITWSLVSTLAPARLLGLTGGVFNFIGNLAAIATPIVIGFLASGDSFAPAITYISVLALAG ALSYILLVGKVERIEL
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server